Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid

Stopped The funding source is not going to fund this anymore. Only two subjects completed the study therefore meaningful analysis not possible.

Conditions

• Dialysis
• Cardiovascular Disease
• Atherosclerosis
• Inflammation

Interventions

• DRUG: Extended Release Nicotinic Acid (Niaspan)

Sponsor

Brigham and Women's Hospital